Alkermes plc. (ALKS): Capital Expenditures
$40.42M
Year ended 2025-12-31
$29.53M
Trailing 12 months to 2026-06-30
+1.9%
3-year compound annual growth
-0.9%
5-year compound annual growth
-2.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.42M | +20.7% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $33.48M | -30.3% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $48.05M | +25.6% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $38.26M | +36.5% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $28.02M | -33.6% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $42.22M | -53.6% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $90.94M | +31.0% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $69.43M | +35.3% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $51.30M | +17.5% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $43.66M | -17.4% | 2019-02-15, From 2016-01-01 |
| 2015-12-31 | $52.88M | +57.1% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $33.65M | n/a | 2017-02-17, From 2014-01-01 |
| No annual figure between 2013-03-31 and 2014-12-31. | |||
| 2013-03-31 | $22.22M | +30.8% | 2015-02-24, From 2012-04-01 |
| 2012-03-31 | $16.99M | +80.7% | 2013-05-23, From 2011-04-01 |
| 2011-03-31 | $9.40M | -40.5% | 2013-05-23, From 2010-04-01 |
| 2010-03-31 | $15.79M | n/a | 2012-05-18, From 2009-04-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $40.42M | +20.7% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $59.09M | +54.3% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $8.86M | +36.3% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $66.00M | +127.6% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $11.18M | +35.9% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $4.69M | +796.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $101.97M | -25.5% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $51.44M | +13.6% |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗